Geographic differences in bone turnover: Data from a multinational study in healthy postmenopausal women

Calcified Tissue International

Volumn 63, Issue 4, 1998, Pages 277-282

  Cohen, F J ^a   Eckert, S ^a   Mitlak, B H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Bone markers; Bone metabolism; Epidemiology; Geography; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; RALOXIFENE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATHOLOGIC FRACTURE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFRICA; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; AUSTRALIA; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; EUROPE; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PIPERIDINES; RALOXIFENE;

EID: 0031660144     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900526     Document Type: Article

References (31)

1. Calvo MS, Eyre DR, Gundberg CM (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocrinol Rev 17:333-368
2. Als OS, Riis BJ, Gotfredsen A, Christiansen C, Deftos LJ (1986) Biochemical markers of bone turnover in rheumatoid arthritis Relation to anti-inflammatory treatment, sex, and menopause. Acta Med Scand 219:209-213
3. Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegard D, Saxne T (1995) Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 95:1071-1077
4. Peel N, Eastell R, Russell G (1992) Markers of bone and collagen breakdown in early inflammatory arthritis. Baillieres Clin Rheumatol 6:351-372
5. Deftos LJ, Wolfert RL, Hill CS (1990) Bone alkaline phosphatase in Paget's disease. Horm Metab 23:559-561
6. Moro L, Gazzarrini C, Crivellari D, Galligioni E, Talamini R, de Bernard B (1993) Biochemical markers for detecting bone metastases in subjects with breast cancer. Clin Chem 39:131-134
7. Garnero P, Sornay-Rendu E, Chapuy M, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349
8. Mallmin H, Ljunghall S, Larsson K, Lindh E (1991) Short-term effects of pamidronate on biochemical markers of bone metabolism in osteoporosis - a placebo-controlled dose-finding study. Ups J Med Sci 96:205-212
9. Garnero P, Shih W, Gineyts E, Karpf D, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700
10. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukrim K, Smith J (1996) Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81:37-43
11. Melton L (1991) Differing patterns of osteoporosis across the world. In: Chesnut CH (ed) New dimensions in osteoporosis in the 1990s. Excerpta Medica, Hong Kong, pp 13-18
12. Cooper C, Campion G, Melton L (1993) Hip fractures in the elderly a worldwide projection. Osteoporosis Int 2:285-289
13. Johnell O, Gullburg B, Allander E, Kanis JA (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporosis Int 2:298-302
14. Nakamura T, Turner CH, Yoshinawa T, Slemenda CW, Peacock M, Burr DB, Mizuno Y, Orimo H, Ouchi Y, Johnston C (1994) Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 9:1071-1076
15. Maggi S, Kelsey JL, Litvak J, Heyse SP (1991) Incidence of hip fractures in the elderly: a cross-national analysis. Osteoporosis Int 1:234-241
16. Salamone LM, Glynn NW, Black DM, Ferrell RE, Palermo L, Epstein RS, Kuller LH, Cauley JA (1996) Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res 11:1557-1565
17. Riis BJ, Hansen MA, Jensen A, Overgaard K, Christiansen C (1996) Low bone mass and fast rate of bone loss at menopause Equal risk factors for future fracture: a 15-year follow-up study. Bone 19:9-12
18. Szulc P, Chapuy M, Meunier P, Delmas PD (1993) Serum undecarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774
19. Garnero P, Hausherr E, Chapuy M, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD (1996) Markers of bone resorption predict hip fractures in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531-1538
20. Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ (1995) Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 10:1823-1829
21. Delmas PD, Garnero P (1996) Utility of biochemical markers of bone turnover in osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 1075-1088
22. Garnero P, Delmas PD (1993) Assessment ot the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in subjects with metabolic bone disease. J Clin Endocrinol Metab 77:1046-1053
23. Garnero P, Gineyts E, Riou J, Delmas PD (1994) Assessment of bone resorption with a new marker of collagen degradation in subjects with metabolic bone disease. J Clin Endocrinol Metab 79:780-785
24. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022-2025
25. Parfitt A, Gallagher J, Heaney R, Johnston C, Neer R, Whedon G (1982) Vitamin D and bone health in the elderly. Am J Clin Nutr 36:1014-1031
26. Feldman D, Malloy P, Coleman (1996) Vitamin D: metabolism and action. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 205-235
27. Krall E, Sahyoun N, Tannenbaum S, Dallal G, Dawson-Hughes B (1989) Effect of vitamin D on seasonal variations in parathyroid secretion in postmenopausal women. N Engl J Med 321:1777-1783
28. Villa M, Nelson L (1996) Race, ethnicity, and osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 435-447
29. Ray W, Griffin M, West R, Strand L, Melton L (1990) Incidence of hip fracture in Saskatchewan, Canada 1976-1985. Am J Epidemiol 131:502-509
30. Lizaur-Utrilla A, Ortis P, Del Campo FS, Barrio JA, Carbonell PG (1987) Epidemiology of trochanteric fractures of the femur in Alicante, Spain, 1974-1982. Clin Orthop Rel Res 218: 24-31
31. Hirsch L, Watts N, McIlwain H, Rodriguez J, Romanowicz A, Daifotis A, Kher U, Santora (1995) Efficacy of alendronate to increase BMD is similar irrespective of baseline bone turnover, BMD, and age. J Bone Miner Res 10 (suppl 1): S350